Academic Collaborations

A close link with leading research groups and experts is an important asset for exploring novel insights in our core competencies, for applying up-to-date scientific know-how and for staying at the forefront of the scientific development. 7TM Pharma has established a number of collaborative alliances with key scientists in the GPCR and metabolic fields:

Panum Institute, University of Copenhagen, Denmark

Department of Molecular Pharmacology, Prof. Thue W. Schwartz

The Laboratory of Molecular Pharmacology at the Panum Institute is an essential part of 7TM Pharma’s scientific base and its research partnerships. 7TM Pharma has acquired exclusive rights to all of the laboratory’s inventions relating to 7TM receptors under a collaborative agreement with the University of Copenhagen. This collaboration allows 7TM Pharma to pursue technology development at a very early stage with less rigid requirements to immediate applicability.

King’s College, UK

7TM Pharma collaborates with Prof. Helen Cox for assessment of the ex vivo efficacy of the Y receptor agonists in human tissue. Prof. Cox has been engaged in work on the Y receptor system for 25 years and has a scientific track record in GI tract cellular function. The access to human tissue is a unique opportunity and asset for 7TM Pharma’s efficacy studies.

University of Leipzig, Germany

Annette Beck-Sickinger, chairman and professor of biochemistry, has extensive experience in structure/function studies and Y peptide synthesis. She assists 7TM Pharma in studies of the kinetic properties of peptide candidates and subsequent modification of lead peptides for PK optimization.

University in Ljubljana, Slovenia

Milka Vrecl, Assist. Prof PhD, has extensive expertise in 7TM receptor signaling and dimerisation. 7TM Pharma has collaborated with Milka Vrecl for several years on investigating pharmacologically important signaling pathways and internalization of selected 7TM receptors. This work is supported by the Danish Slovenian research grant.